Skip to content

Neovision Corp.

United StatesFDA applicant, unverified

Part of Neo Vision Co. Ltd

Devices
2

What Neovision Corp. makes

Neovision Corp. manufactures the HOLOPSY System, a medical imaging device designed for endoscopic visualization, and the SONOPSY LA System, an ultrasound-guided ablation tool for targeted tissue treatment.

These devices are classified as Class II under FDA regulations and are listed via the 510(k) clearance process. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Holopsy System Ref K951999

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Sonopsy La System Ref K980423

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Neovision Corp. have in the registry?

The registry currently lists 2 devices for Neovision Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Neovision Corp.'s devices?

Among its 2 most recently registered devices, Neovision Corp. has devices listed in FDA 510(k) (2 devices).

What risk classes do Neovision Corp.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Neovision Corp.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Neovision Corp. in the registry?

The most recently registered devices listed for Neovision Corp. include HOLOPSY SYSTEM and SONOPSY LA SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.